YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) Increases Dividend to $0.18 Per Share

YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) declared a dividend on Wednesday, January 7th. Stockholders of record on Thursday, January 8th will be paid a dividend of 0.1765 per share on Friday, January 9th. This represents a dividend yield of 5,348.0%. The ex-dividend date is Thursday, January 8th. This is a 698.6% increase from YieldMax MRNA Option Income Strategy ETF’s previous dividend of $0.02.

YieldMax MRNA Option Income Strategy ETF Price Performance

NYSEARCA MRNY traded up $0.15 during trading hours on Wednesday, reaching $17.16. The stock had a trading volume of 98,598 shares, compared to its average volume of 112,342. YieldMax MRNA Option Income Strategy ETF has a 52-week low of $13.60 and a 52-week high of $55.70. The stock has a fifty day moving average of $15.43 and a 200 day moving average of $18.49.

YieldMax MRNA Option Income Strategy ETF Company Profile

The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax.